UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040477
Receipt number R000046200
Scientific Title Effect of cross trainer on the patients with post Total Hip Arthroplasty
Date of disclosure of the study information 2020/05/22
Last modified on 2022/02/15 20:17:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of cross trainer on the patients with post Total Hip Arthroplasty

Acronym

Effect of cross trainer on the patients with post Total Hip Arthroplasty

Scientific Title

Effect of cross trainer on the patients with post Total Hip Arthroplasty

Scientific Title:Acronym

Effect of cross trainer on the patients with post Total Hip Arthroplasty

Region

Japan


Condition

Condition

THA

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to examine the effects of cross-trainer on gait performance and patient satisfaction, muscle activity during gait in patients with post-THA.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

muscle activity during gait in pre and post-THA (Pre, 1month post-THA, 3 month post-THA)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

In the intervention group, in addition to the usual physical therapy, a cross-trainer was performed for 20 minutes a day from 3 to 10 th postoperate days.

Interventions/Control_2

In the control group, in addition to the usual physical therapy, a walking practice was performed for 20 minutes a day from 3 to 10 th postoperate days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Cases admitted to our hospital from the date of approval of ethical examination to March 31, 2022.
2. Patients who can walk 10m without using a cane preoperative.
3. A case in which postoperative physical therapy was started post unilateral total hip arthroplasty.

Key exclusion criteria

1. A case where walking without a cane was difficult preoperative.
2. Patients who underwent THA after fracture.
3. A case where the attending physician ordered ADL restriction due to postoperative complications.
4. A case with severe cognitive impairment (HDS-R 5 points or less)

Target sample size

48


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Hasebe

Organization

Saitama Medical University Graduate School

Division name

School of Medicine

Zip code

350-0496

Address

981 Kawakado, Iruma-gun, Saitama, Japan

TEL

049-295-1001

Email

hasebe_y@saitama-med.ac.jp


Public contact

Name of contact person

1st name Kiyokazu
Middle name
Last name Akasaka

Organization

Saitama Medical University Graduate School

Division name

School of Medicine

Zip code

350-0496

Address

981 Kawakado, Iruma-gun, Saitama, Japan

TEL

049-295-1001

Homepage URL


Email

akasaka-smc@umin.ac.jp


Sponsor or person

Institute

Saitama Medical University Graduate School

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University Graduate School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee of Saitama Medical University Saitama Medical Center

Address

1981, Kamoda, Kawagoe, Saitama, Japan

Tel

049-228-3902

Email

smcrinri@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2020 Year 07 Month 01 Day

Date of IRB

2020 Year 07 Month 11 Day

Anticipated trial start date

2020 Year 07 Month 21 Day

Last follow-up date

2021 Year 09 Month 30 Day

Date of closure to data entry

2021 Year 09 Month 30 Day

Date trial data considered complete

2021 Year 09 Month 30 Day

Date analysis concluded

2022 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2020 Year 05 Month 21 Day

Last modified on

2022 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046200


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name